Telix Pharmaceuticals Limited

Telix Pharmaceuticals develops medicines and diagnostic imaging agents that use radioactive compounds to treat and detect cancers. The company's main focus is on cancers like prostate cancer, kidney cancer, and brain tumors. They have drugs in clinical trials, which are the testing stages required before the government approves medicines for patients. Telix also manufactures these specialized radioactive products for use in hospitals and research centers.